Status:

RECRUITING

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

Alberta Boehringer Ingelheim Collaboration

Conditions:

Fibrotic Interstitial Lung Disease

Eligibility:

All Genders

18-85 years

Phase:

PHASE2

Brief Summary

The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality of life, exercise tol...

Detailed Description

Brief Summary: The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality of li...

Eligibility Criteria

Inclusion

  • Individuals with fibrotic ILD (all sub-groups of ILD) who have normal oxygen saturation at rest (SpO2 \> 90%) but develop exertional hypoxemia as demonstrated by a SpO2 = 80-89% with activity (measured during 6MWT).

Exclusion

  • Use of home oxygen therapy within the previous year for the management of ILD, co-morbid conditions that may require oxygen therapy (such as COPD, cardiovascular disease, or other illnesses), or individuals that require the use of non-invasive ventilation. Additionally, individuals with significant cardiovascular, metabolic, neuromuscular or any other disease that could contribute to dyspnea or abnormal cardiopulmonary responses to exercise will be excluded. Individuals with musculoskeletal injuries that prevent them from completing cycle ergometry exercise trials and ambulation will also be excluded. Individuals with peripheral vascular disease will be excluded from measurement of vascular function (flow mediated dilation).

Key Trial Info

Start Date :

July 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06053164

Start Date

July 1 2025

End Date

September 1 2026

Last Update

December 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Physiology Laboratory

Edmonton, Alberta, Canada, T6G2R3